All4NutraNo products in the cart.
All4NutraStartseite » Polylacticcoglycolic acid – PLGA » Page 9
Drug delivery technologies have been proven to improve treatment outcomes in many ways, including enhancing therapeutic efficacy, reducing toxicity, increasing patient...
The present study deals with the development of dexamethasone (DM)-loaded implants using ester end-capped Resomer RG 502 poly(lactic acid-co-glycolic acid)...
Tuberculosis (TB) is currently the second deadliest infectious disease. Existing antitubercular therapies are long, complex, and have severe side effects...
Diseases affecting the anterior segment of the eye are the primary causes of vision impairment and blindness globally. Drug administration...
Upon extensive pharmaceutical and biomedical research to treat lung cancer indicates that lung cancer remains one of the deadliest diseases...
Topical therapies for chronic skin diseases suffer from a low patient compliance due to the inconvenient treatment regimens of available...
Therapeutic proteins and peptides (TPPs) are increasingly favoured above small drug molecules due to their high specificity to the site...
Abstract This review is devoted to modern systems of nanocarriers that ensure the targeted delivery of flavonoids to various organs...
This work gives a brief overview of carrier materials currently used in pharmaceutical studies on the three-dimensional (3D) semi-solid extrusion...
Poorly soluble drugs must be appropriately formulated for clinical use to increase the solubility, dissolution rate, and permeation across the...
Copyright: PharmaExcipients AG